|
Orthologous residues
|
|
FOXO4 (human): T455‑p, FOXO4 (mouse): A456‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, mutation of modification site, phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
293T (epithelial), 3T3 (fibroblast) [SHP-2 (mouse), homozygous knockout], C2C12 (myoblast)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human, mouse
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
JNK1 (human)
|
genetic knockout/knockin of upstream enzyme
|
|
|
KINASE
|
JNK2 (human)
|
genetic knockout/knockin of upstream enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
H2O2
|
|
|
|
increase
|
|
|
PD98059
|
H2O2
|
|
|
no effect upon treatment-induced increase
|
|
|
LY294002
|
H2O2
|
|
|
no effect upon treatment-induced increase
|
|
|
SB203580
|
H2O2
|
|
|
no effect upon treatment-induced increase
|
|
|
|
|
RalA (human)
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
intracellular localization
|
|
Effect of modification (process):
transcription, altered
|